ARK Genomic Revolution ETF

CURRENTetfsBiomedical Innovation

ARK Genomic Revolution ETF is an exchange-traded wrapper in the Etfs desk. Wrapper structure can affect public ranking, liquidity screens, and home-mover eligibility.

Fund Assets

Not reported

Latest verified fund profile did not include AUM or net assets.

Volume

Not reported

Latest verified quote did not include volume.

Price Data

CURRENT

Coverage

7/7

7D Score Move

—

Needs a prior 7-day score to compare.

Score As Of

1d ago

Signature View · Score Flow

What drives ARKG’s Schema Score

3 contributing indexes 4 score components composite score.

FundamentalsMacroEntryNarrative3 index drivers · Score mix: 45% macro · 27% entry · 27% narrative

What Goes Into This Score · Component Ledger

The current evidence behind ARKG.

Canonical asset packet first: fundamentals, macro index exposure, entry value, and active narrative alignment. Driver rows link back to the public index that moved the score.

Schema Score

Strong Tailwind

Confidence 68%

Reads like a credit score for market support: higher is more supportive.

Fundamentals

quality-growth packet

45% max

Macro Signal

7/7 index inputs

25% max

Entry Value

+0.43% today at $30.67

15% max

Narrative

Biomedical Innovation / Biology Data Platforms

15% max

+0.101 tailwindNet +0.101+0.000 headwind

Index	Driver	Reason	Weight	Condition	Contribution	As Of
RACI	Robotics & Automation Capex Index	research activity	7%	research activity — tailwind Moderate signal —/100Tailwind +0.53σ	+0.041	2026-05-22
BPHI	Biotech & Pharma Health Index	biotech innovation	17%	biotech innovation — tailwind Near normal —/100Tailwind +0.13σ	+0.031	2026-05-22
RQRI	Risk-Quality Rotation Index	risk appetite	3%	risk appetite — tailwind Moderate signal —/100Tailwind +1.30σ	+0.028	2026-05-22

3 components · coverage 100%Schema as of May 22, 5:00 PM EDT

Events & Context

No linked events or headlines yet.